Ascalon International

About:

Ascalon International is an oncology drug development company that creates and manages a portfolio of oncology drugs.

Description:

Ascalon International, Inc., an oncology drug development company, creates and manages a portfolio of oncology drugs. The company also conducts biomarker-based clinical trials in oncology. In addition, it focuses on developing products by clinical development and regulatory execution, either by establishment of a joint development with the product owner or by acquisition of the product. The company has a strategic and operational alliance with Parexel. Ascalon International, Inc. was founded in 2009 and is based in Scottsdale, Arizona.

Total Funding Amount:

$905000

Headquarters Location:

Scottsdale, Arizona, United States

Founded Date:

2009-01-01

Founders:

Keith Benson

Number of Employees:

1-10

Last Funding Date:

2011-12-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai